(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
2 days till quarter result
(bmo 2024-05-07)
Expected move: +/- 1.01%
Live Chart Being Loaded With Signals
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health...
Stats | |
---|---|
今日成交量 | 1 387.00 |
平均成交量 | 2 762.00 |
市值 | 290.58M |
EPS | $-0.480 ( 2023-09-29 ) |
下一个收益日期 | ( $0 ) 2024-05-07 |
Last Dividend | $0.523 ( 2023-10-04 ) |
Next Dividend | $0 ( N/A ) |
P/E | 24.97 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-08 | Hughes Owen | Buy | 275 000 | Performance Stock Units |
2023-10-03 | Sitko Bradley | Buy | 250 | Common Stock |
2023-10-02 | Sitko Bradley | Buy | 1 500 | Common Stock |
2023-10-02 | Hughes Owen | Buy | 1 000 | Common Stock |
2023-09-26 | Hughes Owen | Buy | 2 499 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 95 transactions |
Buy: 1 979 429 | Sell: 840 426 |
XOMA Corporation 财务报表
Annual | 2023 |
营收: | $4.76M |
毛利润: | $3.86M (81.08 %) |
EPS: | $-3.56 |
FY | 2023 |
营收: | $4.76M |
毛利润: | $3.86M (81.08 %) |
EPS: | $-3.56 |
FY | 2022 |
营收: | $6.03M |
毛利润: | $5.93M (98.39 %) |
EPS: | $-1.500 |
FY | 2021 |
营收: | $38.16M |
毛利润: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
XOMA Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.523 (N/A) |
$0 (N/A) |
$0.523 (N/A) |
$1.047 (N/A) |
$0 (N/A) |
$0.523 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.558 | 2021-07-01 |
Last Dividend | $0.523 | 2023-10-04 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-16 | |
Next Payout Date | N/A | |
# dividends | 10 | -- |
Total Paid Out | $5.27 | -- |
Avg. Dividend % Per Year | 4.67% | -- |
Score | 3.47 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2021 | $1.081 | 4.38% |
2022 | $2.09 | 8.11% |
2023 | $2.09 | 8.70% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -10.24 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.208 | 1.200 | -6.93 | -8.32 | [0 - 0.3] |
returnOnEquityTTM | -0.465 | 1.500 | -6.28 | -9.42 | [0.1 - 1] |
payoutRatioTTM | -0.112 | -1.000 | -1.123 | 1.123 | [0 - 1] |
currentRatioTTM | 8.68 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 8.66 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 7.87 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.530 | -1.500 | 1.171 | -1.757 | [0 - 0.6] |
interestCoverageTTM | -130.17 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.582 | 2.00 | -0.527 | -1.055 | [0 - 30] |
freeCashFlowPerShareTTM | -2.86 | 2.00 | -1.430 | -2.86 | [0 - 20] |
debtEquityRatioTTM | 1.399 | -1.500 | 4.40 | -6.61 | [0 - 2.5] |
grossProfitMarginTTM | 0.811 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -5.80 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.146 | 1.000 | -1.924 | -1.924 | [0.2 - 2] |
assetTurnoverTTM | 0.0203 | 0.800 | -3.20 | -2.56 | [0.5 - 2] |
Total Score | -1.689 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -5.84 | 1.000 | -0.690 | 0 | [1 - 100] |
returnOnEquityTTM | -0.465 | 2.50 | -4.04 | -9.42 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -2.86 | 2.00 | -0.953 | -2.86 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.582 | 2.00 | -0.527 | -1.055 | [0 - 30] |
payoutRatioTTM | -0.112 | 1.500 | -1.123 | 1.123 | [0 - 1] |
pegRatioTTM | -0.115 | 1.500 | -4.10 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -3.82 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -3.15 |
XOMA Corporation
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。